| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Christopher D Howard, Kristen A Keefe, Paul A Garris, David P Daberko. Methamphetamine neurotoxicity decreases phasic, but not tonic, dopaminergic signaling in the rat striatum. Journal of neurochemistry. vol 118. issue 4. 2011-09-16. PMID:21668447. |
extracellular da was electrically evoked by stimulation of the medial forebrain bundle mimicking tonic and phasic firing patterns for dopaminergic cells and was monitored simultaneously in both the dorsomedial and dorsolateral striatum. |
2011-09-16 |
2023-08-12 |
rat |
| M Flint Bea. Neuroprotective effects of creatine. Amino acids. vol 40. issue 5. 2011-09-15. PMID:21448659. |
creatine produced dose-dependent neuroprotective effects against mptp toxicity reducing the loss of dopamine within the striatum and the loss of dopaminergic neurons in the substantia nigra. |
2011-09-15 |
2023-08-12 |
mouse |
| Robbert Havekes, Ted Abel, Eddy A Van der Ze. The cholinergic system and neostriatal memory functions. Behavioural brain research. vol 221. issue 2. 2011-09-09. PMID:21129408. |
pharmacological and genetic manipulations have indicated that the cholinergic and dopaminergic system in the striatum modulate each other's function. |
2011-09-09 |
2023-08-12 |
Not clear |
| Robbert Havekes, Ted Abel, Eddy A Van der Ze. The cholinergic system and neostriatal memory functions. Behavioural brain research. vol 221. issue 2. 2011-09-09. PMID:21129408. |
together, these data indicate that the cholinergic system in the striatum is involved in a diverse set of cognitive functions through interactions with other neurotransmitter systems including the dopaminergic and gabaergic systems. |
2011-09-09 |
2023-08-12 |
Not clear |
| Hironori Yokoyama, Ryohei Yano, Hayato Kuroiwa, Tatsuya Tsukada, Hiroto Uchida, Hiroyuki Kato, Jiro Kasahara, Tsutomu Arak. Therapeutic effect of a novel anti-parkinsonian agent zonisamide against MPTP (1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine) neurotoxicity in mice. Metabolic brain disease. vol 25. issue 3. 2011-09-06. PMID:20957419. |
our western blot analysis and immunohistochemical study showed that the post-treatment with zonisamide prevented significantly dopaminergic cell damage, the depletion of tyrosine-hydroxylase (th) protein levels and the proliferation of microglia in the striatum and/or substantia nigra 8 days after mptp treatment. |
2011-09-06 |
2023-08-12 |
mouse |
| Marios Politi. Optimizing functional imaging protocols for assessing the outcome of fetal cell transplantation in Parkinson's disease. BMC medicine. vol 9. 2011-08-30. PMID:21569273. |
clinical trials aiming to assess the safety and efficacy of fetal cell transplantation in parkinson's disease rely on the hypothesis that the grafted tissue will survive and grow, restore striatal dopaminergic neurotransmission, improve the connectivity between striatum, thalamus and cortex and, thereby, produce long-lasting clinical improvement while avoiding the development of adverse effects. |
2011-08-30 |
2023-08-12 |
human |
| Torsten Falk, Xu Yue, Shiling Zhang, Alexander D McCourt, Brandon J Yee, Robert T Gonzalez, Scott J Sherma. Vascular endothelial growth factor-B is neuroprotective in an in vivo rat model of Parkinson's disease. Neuroscience letters. vol 496. issue 1. 2011-08-26. PMID:21507340. |
immunohistochemical analysis showed that vegf-b(186) treatment partially protected dopaminergic fibers in the striatum and demonstrated a partial rescue of the dopaminergic neurons in the caudal sub-region of the substantia nigra. |
2011-08-26 |
2023-08-12 |
rat |
| Delphine Michel-Monigadon, Virginie Bonnamain, Véronique Nerrière-Daguin, Anne-Sophie Dugast, Xavier Lévèque, Martine Plat, Eric Venturi, Philippe Brachet, Ignacio Anegon, Bernard Vanhove, Isabelle Neveu, Philippe Naveilha. Trophic and immunoregulatory properties of neural precursor cells: benefit for intracerebral transplantation. Experimental neurology. vol 230. issue 1. 2011-08-12. PMID:20470774. |
in addition to their immunosuppressive effect, in contrast to pnb, very few pnspc differentiated into tyrosine hydroxylase-positive neurons but the cells triggered an intense innervation of the striatum by rat dopaminergic fibers coming from the substantia nigra. |
2011-08-12 |
2023-08-12 |
human |
| Sang Hee Kim, Sang-Hyun Baik, Chang Soo Park, Su Jin Kim, Sung Won Choi, Sang Eun Ki. Reduced striatal dopamine D2 receptors in people with Internet addiction. Neuroreport. vol 22. issue 8. 2011-08-12. PMID:21499141. |
we hypothesized that internet addiction would be associated with reduced levels of dopaminergic receptor availability in the striatum compared with controls. |
2011-08-12 |
2023-08-12 |
Not clear |
| Marc Guitart-Masip, Lluis Fuentemilla, Dominik R Bach, Quentin J M Huys, Peter Dayan, Raymond J Dolan, Emrah Duze. Action dominates valence in anticipatory representations in the human striatum and dopaminergic midbrain. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 31. issue 21. 2011-08-04. PMID:21613500. |
action dominates valence in anticipatory representations in the human striatum and dopaminergic midbrain. |
2011-08-04 |
2023-08-12 |
human |
| Eric S Ramsson, Daniel P Covey, David P Daberkow, Melissa T Litherland, Steven A Juliano, Paul A Garri. Amphetamine augments action potential-dependent dopaminergic signaling in the striatum in vivo. Journal of neurochemistry. vol 117. issue 6. 2011-08-03. PMID:21443523. |
amphetamine augments action potential-dependent dopaminergic signaling in the striatum in vivo. |
2011-08-03 |
2023-08-12 |
rat |
| Jonathan Moss, Mark A Ungless, J Paul Bola. Dopaminergic axons in different divisions of the adult rat striatal complex do not express vesicular glutamate transporters. The European journal of neuroscience. vol 33. issue 7. 2011-07-18. PMID:21375596. |
here, we provide further support for this view by showing that dopaminergic axons and terminals in subregions of the adult striatum do not express vesicular glutamate transporters (vglut1, vglut2 or vglut3). |
2011-07-18 |
2023-08-12 |
rat |
| Jonathan Moss, Mark A Ungless, J Paul Bola. Dopaminergic axons in different divisions of the adult rat striatal complex do not express vesicular glutamate transporters. The European journal of neuroscience. vol 33. issue 7. 2011-07-18. PMID:21375596. |
we found that dopaminergic axons and terminals in the dorsolateral striatum and ventral striatum (nucleus accumbens core and shell) do not express vglut1, vglut2 or vglut3. |
2011-07-18 |
2023-08-12 |
rat |
| Jonathan Moss, Mark A Ungless, J Paul Bola. Dopaminergic axons in different divisions of the adult rat striatal complex do not express vesicular glutamate transporters. The European journal of neuroscience. vol 33. issue 7. 2011-07-18. PMID:21375596. |
we conclude, therefore, that in the normal, adult rat striatum, dopaminergic axons do not co-release glutamate. |
2011-07-18 |
2023-08-12 |
rat |
| b' Susanna Amadio, Cinzia Montilli, Barbara Picconi, Paolo Calabresi, Cinzia Volont\\xc3\\xa. Mapping P2X and P2Y receptor proteins in striatum and substantia nigra: An immunohistological study. Purinergic signalling. vol 3. issue 4. 2011-07-14. PMID:18404452.' |
this generates a rearrangement of p2 proteins: most p2x and p2y receptors are decreased on gabaergic and dopaminergic neurons, in the lesioned striatum and substantia nigra, respectively, as a consequence of dopaminergic denervation and/or neuronal degeneration. |
2011-07-14 |
2023-08-12 |
rat |
| Marek Cieślak, Michał Komoszyński, Andrzej Wojtcza. Adenosine A(2A) receptors in Parkinson's disease treatment. Purinergic signalling. vol 4. issue 4. 2011-07-14. PMID:18438720. |
co-localization of adenosine a(2a) and dopaminergic d2 receptors in striatum creates a milieu for antagonistic interaction between adenosine and dopamine. |
2011-07-14 |
2023-08-12 |
Not clear |
| Torsten Falk, Shiling Zhang, Scott J Sherma. Vascular endothelial growth factor B (VEGF-B) is up-regulated and exogenous VEGF-B is neuroprotective in a culture model of Parkinson's disease. Molecular neurodegeneration. vol 4. 2011-07-14. PMID:20003314. |
parkinson's disease (pd) results from the degeneration of dopaminergic neurons in the substantia nigra and the consequent deficit of dopamine released in the striatum. |
2011-07-14 |
2023-08-12 |
rat |
| Hongyu Wang, Xi Chen, Yuemei Li, Tie-Shan Tang, Ilya Bezprozvann. Tetrabenazine is neuroprotective in Huntington's disease mice. Molecular neurodegeneration. vol 5. 2011-07-14. PMID:20420689. |
tbz acts by reducing dopaminergic input to the striatum. |
2011-07-14 |
2023-08-12 |
mouse |
| M T Tadaiesky, P A Dombrowski, C Da Cunha, R N Takahash. Effects of SR141716A on Cognitive and Depression-Related Behavior in an Animal Model of Premotor Parkinson's Disease. Parkinson's disease. vol 2010. 2011-07-14. PMID:20976080. |
these findings suggest a role for cb(1) receptors in the early symptoms caused by degeneration of dopaminergic neurons in the striatum, as observed in parkinson's disease. |
2011-07-14 |
2023-08-12 |
rat |
| Susanne Graef, Guido Biele, Lea K Krugel, Frank Marzinzik, Michael Wahl, Johann Wotka, Fabian Klostermann, Hauke R Heekere. Differential influence of levodopa on reward-based learning in Parkinson's disease. Frontiers in human neuroscience. vol 4. 2011-07-14. PMID:21048900. |
the mesocorticolimbic dopamine (da) system linking the dopaminergic midbrain to the prefrontal cortex and subcortical striatum has been shown to be sensitive to reinforcement in animals and humans. |
2011-07-14 |
2023-08-12 |
Not clear |